MISSISSAUGA, Ontario, March 13, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December ...

BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December ...

At close: March 7 at 3:59:47 PM EST Loading Chart for RX.V ...

374341000033111 325557008 Conjugated oestrogens 1.25mg tablets Conjugated oestrogens 1.25mg tablets Conjugated oestrogens 1.250mg Tablet Oral 6040101 300000 374441000033117 325556004 Conjugated ...

Everyday use of drugs was associated with an increased prevalence of constipation and diarrhoea, and polypharmacy with an additional risk of diarrhoea in the general population. Furosemide ...